Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Iodine-131 5dabrafenib 4Vemurafenib 4Magnetic Resonance Spectroscopy 4trametinib 3lenvatinib 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Thyroidectomy 3selpercatinib 2cobimetinib 2X-Rays 2Thyroid (USP) 2Surgical Procedures, Operative 2Sunitinib 2Specimen Handling 2Radiofrequency Ablation 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1pembrolizumab 1pazopanib 1durvalumab 1delta 24-sterol reductase 1copanlisib 1cabozantinib 1Whole Body Imaging 1Thyrotropin 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Cancer, Papillary × Celecoxib × Clear all
NCT00061906 2014-02-11

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
25 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡